David Chardin

460 total citations
24 papers, 289 citations indexed

About

David Chardin is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David Chardin has authored 24 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in David Chardin's work include Radiomics and Machine Learning in Medical Imaging (9 papers), Medical Imaging Techniques and Applications (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). David Chardin is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (9 papers), Medical Imaging Techniques and Applications (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). David Chardin collaborates with scholars based in France, United States and Monaco. David Chardin's co-authors include Olivier Humbert, Jacques Darcourt, Josiane Otto, Renaud Schiappa, M. Poudenx, Marius Ilié, Nicolas Martin, Caroline Bailleux, Jonathan Benzaquen and Jocelyn Gal and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and BMC Bioinformatics.

In The Last Decade

David Chardin

20 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Chardin France 8 154 142 110 43 36 24 289
J. Madelaine France 10 223 1.4× 105 0.7× 208 1.9× 33 0.8× 41 1.1× 33 406
Yuhui Liu China 9 102 0.7× 191 1.3× 142 1.3× 32 0.7× 51 1.4× 27 324
Joaquín Mosquera Spain 12 305 2.0× 55 0.4× 226 2.1× 71 1.7× 53 1.5× 39 457
Letizia Laera Italy 12 119 0.8× 51 0.4× 179 1.6× 72 1.7× 101 2.8× 32 329
Ray Manneh Kopp Spain 9 69 0.4× 33 0.2× 83 0.8× 44 1.0× 38 1.1× 35 172
Honghai Dai China 11 136 0.9× 167 1.2× 236 2.1× 17 0.4× 42 1.2× 14 355
Antonino Cassata Italy 9 220 1.4× 49 0.3× 54 0.5× 35 0.8× 47 1.3× 21 292
Neal S. McCall United States 10 210 1.4× 73 0.5× 118 1.1× 26 0.6× 55 1.5× 29 367
Gennaro Palmiotti Italy 9 163 1.1× 55 0.4× 105 1.0× 61 1.4× 74 2.1× 22 332
Yangsen Cao China 10 180 1.2× 76 0.5× 105 1.0× 62 1.4× 21 0.6× 30 255

Countries citing papers authored by David Chardin

Since Specialization
Citations

This map shows the geographic impact of David Chardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chardin more than expected).

Fields of papers citing papers by David Chardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chardin. The network helps show where David Chardin may publish in the future.

Co-authorship network of co-authors of David Chardin

This figure shows the co-authorship network connecting the top 25 collaborators of David Chardin. A scholar is included among the top collaborators of David Chardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chardin. David Chardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chardin, David, et al.. (2024). Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy. Journal for ImmunoTherapy of Cancer. 12(4). e007628–e007628. 15 indexed citations
2.
3.
Chardin, David, et al.. (2024). [18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal. European Journal of Nuclear Medicine and Molecular Imaging. 51(12). 3696–3708. 3 indexed citations
4.
Chardin, David, Jean‐Marie Guigonis, Valérie Rigau, et al.. (2023). Identification of Metabolomic Markers in Frozen or Formalin-Fixed and Paraffin-Embedded Samples of Diffuse Glioma from Adults. International Journal of Molecular Sciences. 24(23). 16697–16697. 4 indexed citations
5.
Bailleux, Caroline, David Chardin, Jocelyn Gal, et al.. (2023). Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer. Cancers. 15(7). 1941–1941.
6.
Darcourt, Jacques, David Chardin, Véronique Bourg, et al.. (2023). Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2727–2735. 4 indexed citations
7.
Bailleux, Caroline, C. Zwarthoed, Ludovic Evesque, et al.. (2023). Prognostic impact of post-treatment FDG PET/CT in anal canal cancer: A prospective study. Radiotherapy and Oncology. 188. 109905–109905.
8.
Bailleux, Caroline, David Chardin, Jean‐Marie Guigonis, et al.. (2023). Survival analysis of patient groups defined by unsupervised machine learning clustering methods based on patient metabolomic data.. Computational and Structural Biotechnology Journal. 21. 5136–5143. 1 indexed citations
9.
Giordana, Caroline, et al.. (2023). [18F]-FDopa positron emission tomography imaging in corticobasal syndrome. Brain Imaging and Behavior. 17(6). 619–627. 1 indexed citations
10.
Chardin, David, et al.. (2022). Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3787–3796. 10 indexed citations
11.
12.
Humbert, Olivier, Matteo Bauckneht, Jocelyn Gal, et al.. (2022). Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3878–3891. 9 indexed citations
13.
Chardin, David, Olivier Humbert, Caroline Bailleux, et al.. (2021). Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection—an application in metabolomics studies. BMC Bioinformatics. 22(1). 594–594. 2 indexed citations
14.
Humbert, Olivier & David Chardin. (2020). Dissociated Response in Metastatic Cancer: An Atypical Pattern Brought Into the Spotlight With Immunotherapy. Frontiers in Oncology. 10. 566297–566297. 50 indexed citations
15.
Gal, Jocelyn, Caroline Bailleux, David Chardin, et al.. (2020). Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer. Computational and Structural Biotechnology Journal. 18. 1509–1524. 22 indexed citations
16.
Chardin, David, et al.. (2020). La sarcoïdose pour les nuls… et plus si affinités !. 3(1). 36–46.
17.
Chardin, David, Renaud Schiappa, Jacques Darcourt, et al.. (2020). Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study. Journal for ImmunoTherapy of Cancer. 8(2). e000645–e000645. 61 indexed citations
18.
Humbert, Olivier, Renaud Schiappa, M. Poudenx, et al.. (2019). 18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns. European Journal of Nuclear Medicine and Molecular Imaging. 47(5). 1158–1167. 61 indexed citations
19.
Humbert, Olivier, Jean‐Marc Riedinger, David Chardin, et al.. (2019). SUV calculation in breast cancer: which normalization should be applied when using 18F-FDG PET?. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 63(4). 399–407. 1 indexed citations
20.
Chardin, David, et al.. (2017). False positive 18FDG PET-CT results due to exogenous lipoid pneumonia secondary to oily drug inhalation. Medicine. 96(22). e6889–e6889. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Madelaine Breakdown of academic impact, for papers by Yuhui Liu Breakdown of academic impact, for papers by Joaquín Mosquera Breakdown of academic impact, for papers by Letizia Laera Breakdown of academic impact, for papers by Ray Manneh Kopp Breakdown of academic impact, for papers by Honghai Dai Breakdown of academic impact, for papers by Antonino Cassata Breakdown of academic impact, for papers by Neal S. McCall Breakdown of academic impact, for papers by Gennaro Palmiotti Breakdown of academic impact, for papers by Yangsen Cao
Rankless by CCL
2026